» Articles » PMID: 36693607

Synthesis of Biodegradable Antimicrobial PH-sensitive Silver Nanocomposites Reliant on Chitosan and Carrageenan Derivatives for 5-fluorouracil Drug Delivery Toward HCT116 Cancer Cells

Overview
Publisher Elsevier
Date 2023 Jan 24
PMID 36693607
Authors
Affiliations
Soon will be listed here.
Abstract

The current research relies on a one-pot green biosynthesis of silver nanoparticles (SNPs) with various ratios of silver (Ag) in the existence of N, N, N-trimethyl chitosan chloride (TMC) and carboxymethyl kappa-carrageenan (CMKC), to investigate the effectiveness of the synthesized silver nanocomposites (SNCs) as pH sensitive biodegradable carrier for orally intestinal delivery of 5-fluorouracil (5-FU) drug. FTIR, XRD, TEM and FE-SEM/EDX methods were utilized to demonstrate the structure of the prepared polyelectrolyte complex PEC (TMC/CMKC) and SNCs (TMC/CMKC/Ag). The results showed that the 5-FU encapsulation effectiveness inside all of the prepared SNCs samples was improved by increasing the concentration of Ag, reaching 92.16 ± 0.57 % with 3 % Ag. In vitro release behavior of 5-FU loaded SNC 3 % (TMC/CMKC/Ag 3 %), displayed slow and sustained release reaching 96.3 ± 0.81 % up to 24 h into pH 7.4 medium. The successful release of 5-FU from the loaded SNC 3 % was confirmed through occurrence of strong cytotoxicity, with an IC value of 31.15 μg/ml, and high % of apoptotic cells (30.66 %) within the treated HCT116 cells. Besides, SNC 3 % showed good biodegradability and antimicrobial properties against different bacterial strains. Overall, SNC 3 % can be suggested as an effective system for both controlled drug delivery and antibacterial action.

Citing Articles

Analysis of the mechanisms underlying the anticancer and biological activity of retinoic acid and chitosan nanoparticles containing retinoic acid.

Dogan M Med Oncol. 2024; 41(11):251.

PMID: 39320578 DOI: 10.1007/s12032-024-02512-4.


Recent Advancements in Metallic Au- and Ag-Based Chitosan Nanocomposite Derivatives for Enhanced Anticancer Drug Delivery.

El-Meligy M, Abd El-Monaem E, Eltaweil A, Mohy-Eldin M, Ziora Z, Heydari A Molecules. 2024; 29(10).

PMID: 38792255 PMC: 11124311. DOI: 10.3390/molecules29102393.


The cross talk between type II diabetic microenvironment and the regenerative capacities of human adipose tissue-derived pericytes: a promising cell therapy.

Ahmed T, Ahmed S, Elkhenany H, El-Desouky M, Magdeldin S, Osama A Stem Cell Res Ther. 2024; 15(1):36.

PMID: 38331889 PMC: 10854071. DOI: 10.1186/s13287-024-03643-1.


Nanotechnology-driven improvisation of red algae-derived carrageenan for industrial and bio-medical applications.

James J, Verma M, Sharma N World J Microbiol Biotechnol. 2023; 40(1):4.

PMID: 37923917 DOI: 10.1007/s11274-023-03787-x.


Inorganic Nanomaterials Used in Anti-Cancer Therapies:Further Developments.

Dlugosz O, Matyjasik W, Hodacka G, Szostak K, Matysik J, Krawczyk P Nanomaterials (Basel). 2023; 13(6).

PMID: 36986024 PMC: 10051539. DOI: 10.3390/nano13061130.